Healthy Skepticism Library item: 7232
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: news
Baron M.
Pfizer unable to present data due to early disclosure, WSJ
Market Watch.com 2006 Nov 13
http://www.marketwatch.com/News/Story/Story.aspx?guid=%7b139F24D7-2737-498D-880E-9F90F37054A7%7d&siteid=yhoo&dist=yhoo
Abstract:
Pfizer Inc. won’t be able to present new data on an experimental drug designed to boost good cholesterol to the American Heart Association this week due to a violation of the organization’s disclosure guidelines, The Wall Street Journal reported on Monday. The WSJ said a release about the drug, called torcetrapib, issued by Pfizer on Oct. 30 led to the decision by the American Heart Association. Shares of Pfizer, a Dow component, closed Friday at $25.71, down 13 cents
